Business Context and Reporting Period
Company: SBC Medical Group Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 14, 2026
Reporting Period: First Quarter ended March 31, 2026
Business Overview: The Company operates in the medical group sector and is an emerging growth company. It has common stock (SBC) and redeemable warrants (SBCWW) listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) and an investor presentation. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity for the quarter ended March 31, 2026. Investors must refer to the attached Exhibit 99.1 or the investor presentation for these figures.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of Q1 2026 results.
Guidance, Outlook, and Risks
- Management Commentary: The Company posted a "1Q 2026 Investor Presentation" on its website providing an overview of its business.
- Disclosure Policy: The Company utilizes its website to distribute material information, including SEC filings and press releases. Investors are advised to monitor the website and opt-in for email alerts.
- Legal Status of Information: Information furnished under Item 2.02 (Results of Operations) and Item 7.01 (Regulation FD Disclosure) is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 financial results, as they are not included in this 8-K text.
- Access the 1Q 2026 Investor Presentation on the Company's investor relations website for business overviews and potential guidance.
- Verify the exercise price of $11.50 for the redeemable warrants (SBCWW) if evaluating equity instruments.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.